Sign in
4

Changes in Ownership

INOVIO PHARMACEUTICALS, INC. Filed Acc 0001055726-22-000009

Chief Executive Officer gave up 20,045 shares (to pay taxes)

  • Chief Executive Officer acquired 68,767 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Kim Jong Joseph · Chief Executive Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2022-02-26 Exercise or conversion : show line 1 in the form +68,767 1,297,425 D
2022-02-26 Shares withheld for taxes : show line 2 in the form −20,045 $3.22 $64,545 1,277,380 D

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2022-02-26 Exercise or conversion : show line 3 in the form Restricted Stock Unit −68,767 137,533 D
2022-02-26 Grant or award : show line 4 in the form Common Stock Option +627,700 627,700 D
2022-02-26 Grant or award : show line 5 in the form Restricted Stock Unit +468,500 468,500 D
Loading xslF345X03/wf-form4_164617791888639.xml…